Company profile
The Cooper Companies, Inc., together with its affiliates, primarily concentrates on the design, production, and worldwide distribution of contact lenses. The firm organizes its activities into two principal divisions: CooperVision and CooperSurgical. The CooperVision segment supplies a broad selection of contact lenses. This includes spherical lenses crafted to rectify both nearsightedness and farsightedness, alongside advanced toric and multifocal lenses engineered to manage complex visual impairments such as astigmatism, presbyopia, myopia, dry eye, and eye strain. These optical products are made available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Conversely, the CooperSurgical division is committed to enhancing family and women's healthcare globally. It furnishes medical equipment, reproductive health solutions, genomic services, diagnostic tools, and contraceptive options to healthcare professionals and patients alike. This segment’s offerings encompass various surgical and clinic-based products, notably PARAGARD, uterine manipulators, retractors, wound closure items, point-of-care devices, LEEP products, endosee, illuminate, and fetal pillows. Furthermore, it delivers fertility-related goods and services, including specialized consumables, equipment, embryo options, and advanced preimplantation genetic testing. The Cooper Companies, Inc. was established in 1958 and its corporate headquarters are situated in San Ramon, California.
- CEO
- Albert G. White
- Employees
- 15,000
- IPO date
- 29 Jan 2018
- ISIN
- US2166485019
